We establish gut integrity first, then layer additional peptides and therapies onto a healthier foundation
Payandeh Z, Rajabibazl M, Mortazavi Y, Rahimpour A, Taromchi AH
0.1% (placebo) Steady State: Achieved after 4-5 weeks of weekly dosing Safety: Nausea (68% at 4.5 mg), vomiting (32%), generally mild-moderate and transient Discontinuation: 14% discontinued due to GI adverse events Appetite Effects: Significant reductions in Visual Analogue Scale (VAS) hunger scores Publication: Lau DCW, et al
Counteraction of perforated cecum lesions in rats: Effects of pentadecapeptide BPC [PMID: 30622376] Laboratory literature summary: Counteraction of perforated cecum lesions in rats: Effects of pentadecapeptide BPC 157, L-NAME and L-arginine
This isn't just another facial it's a collagen-boosting, skin-rejuvenating powerhouse that'll have clients coming back for more
Research Supplies for BPC-157 Hand-picked storage, injection, and recovery supplies paired with BPC-157 protocols